Neuropeptide y modulates fracture healing through Y1 receptor signaling

Journal of Orthopaedic Research

Volumn 31, Issue 10, 2013, Pages 1570-1578

  Sousa, Daniela M ^a,b   McDonald, Michelle M ^c   Mikulec, Kathy ^c   Peacock, Lauren ^c   Herzog, Herbert ^d,e   Lamghari, Meriem ^a,b   Little, David G ^c   Baldock, Paul A ^d,e  

^a INEB INSTITUTO DE ENGENHARIA BIOMÉDICA   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^d GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^e UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

bone; fracture healing; nervous system; neuropeptide Y; Y1 receptor

Indexed keywords

G PROTEIN COUPLED RECEPTOR; NEUROPEPTIDE Y; UNCLASSIFIED DRUG; Y 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE MASS; BONE REGENERATION; BONE REMODELING; CALLUS; CARTILAGE; CONTROLLED STUDY; FRACTURE HEALING; GENE DELETION; GENOTYPE; KNOCKOUT MOUSE; MICRO-COMPUTED TOMOGRAPHY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TIBIA FRACTURE;

BONE; FRACTURE HEALING; NERVOUS SYSTEM; NEUROPEPTIDE Y; Y1 RECEPTOR;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; FRACTURE HEALING; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUROPEPTIDE Y; OSTEOBLASTS; RECEPTORS, NEUROPEPTIDE Y; SIGNAL TRANSDUCTION; TIBIA; TIBIAL FRACTURES; X-RAY MICROTOMOGRAPHY;

EID: 84882886747     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22400     Document Type: Article

References (38)

1. Ai-Aql ZS, Alagl AS, Graves DT, et al. 2008. Molecular mechanisms controlling bone formation during fracture healing and distraction osteogenesis. J Dent Res 87: 107-118.
2. Schindeler A, McDonald MM, Bokko P, et al. 2008. Bone remodeling during fracture repair: the cellular picture. Semin Cell Dev Biol 19: 459-466.
3. Li J, Ahmad T, Spetea M, et al. 2001. Bone reinnervation after fracture: a study in the rat. J Bone Miner Res 16: 1505-1510.
4. Chenu C., 2004. Role of innervation in the control of bone remodeling. J Musculoskel Neuron Interact 4: 132-134.
5. Madsen JE, Hukkanen M, Aune AK, et al. 1998. Fracture healing and callus innervation after peripheral nerve resection in rats. Clin Orthop Relat Res 351: 230-240.
6. Grills BL, Schuijers JA, Ward AR., 1997. Topical application of nerve growth factor improves fracture healing in rats. J Orthopaed Res 15: 235-242.
7. Nagano J, Tada K, Masatomi T, et al. 1989. Arthropathy of the wrist in leprosy-what changes are caused by long-standing peripheral-nerve palsy. Arch Orthop Traum Surg 108: 210-217.
8. Santavirta S, Konttinen YT, Nordstrom D, et al. 1992. Immunological studies of nonunited fractures. Acta Orthop Scand 63: 579-586.
9. Rusanen M, Korkala O, Gronblad M, et al. 1987. Evolution of substance P immunofluorescent nerves in callus tissue during fracture healing. J Trauma 27: 1340-1343.
10. Hukkanen M, Konttinen YT, Santavirta S, et al. 1993. Rapid proliferation of calcitonin gene-related peptide-immunoreactive nerves during healing of rat tibial fracture suggests neural involvement in bone growth and remodelling. Neuroscience 54: 969-979.
11. Li J, Kreicbergs A, Bergstrom J, et al. 2007. Site-specific CGRP innervation coincides with bone formation during fracture healing and modeling: a study in rat angulated tibia. J Orthop Res 25: 1204-1212.
12. Long H, Ahmed M, Ackermann P, et al. 2010. Neuropeptide Y innervation during fracture healing and remodeling. A study of angulated tibial fractures in the rat. Acta Orthop 81: 639-646.
13. Teixeira L, Sousa DM, Nunes AF, et al. 2009. NPY revealed as a critical modulator of osteoblast function in vitro: new insights into the role of Y1 and Y2 receptors. J Cell Biochem 107: 908-916.
14. Lee NJ, Doyle KL, Sainsbury A, et al. 2010. Critical role for Y1 receptors in mesenchymal progenitor cell differentiation and osteoblast activity. J Bone Miner Res 25: 1736-1747.
15. Baldock PA, Lee NJ, Driessler F, et al. 2009. Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight. PLoS ONE 4: e8415.
16. Bjurholm A, Kreicbergs A, Terenius L, et al. 1988. Neuropeptide Y-, tyrosine hydroxylase- and vasoactive intestinal polypeptide-immunoreactive nerves in bone and surrounding tissues. J Auton Nerv Syst 25: 119-125.
17. Hill EL, Elde R., 1991. Distribution of CGRP-, VIP-, DβH-, SP-, and NPY-immunoreactive nerves in the periosteum of the rat. Cell Tissue Res 264: 469-480.
18. Sousa DM, Lamghari M, Herzog H., 2009. NPY signalling pathway in bone homeostasis: Y1 receptor as a potential drug target. Curr Drug Targets 10: 9-19.
19. Baldock PA, Sainsbury A, Couzens M, et al. 2002. Hypothalamic Y2 receptors regulate bone formation. J Clin Invest 109: 915-921.
20. Lundberg P, Allison SJ, Lee NJ, et al. 2007. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression. J Biol Chem 282: 19082-19091.
21. Baldock PA, Allison SJ, Lundberg P, et al. 2007. Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis. J Biol Chem 282: 19092-19102.
22. Lee NJ, Nguyen AD, Enriquez RF, et al. 2011. Osteoblast specific Y1 receptor deletion enhances bone mass. Bone 48: 461-467.
23. Igwe JC, Jiang X, Paic F, et al. 2009. Neuropeptide Y is expressed by osteocytes and can inhibit osteoblastic activity. J Cell Biochem 108: 621-630.
24. Sousa DM, Baldock PA, Enriquez RF, et al. 2012. Neuropeptide Y Y1 receptor antagonism increases bone mass in mice. Bone 51: 8-16.
25. Howell OW, Scharfman HE, Herzog H, et al. 2003. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem 86: 646-659.
26. Schindeler A, Morse A, Harry L, et al. 2008. Models of tibial fracture healing in normal and Nf1-deficient mice. J Orthop Res 26: 1053-1060.
27. McDonald MM, Morse A, Peacock L, et al. 2011. Characterization of the bone phenotype and fracture repair in osteopetrotic incisors absent rats. J Orthop Res 29: 726-733.
28. Lin S, Boey D, Herzog H., 2004. NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189-200.
29. Wheway J, Herzog H, Mackay F., 2007. The Y1 receptor for NPY: a key modulator of the adaptive immune system. Peptides 28: 453-458.
30. Wheway J, Herzog H, Mackay F., 2007. NPY and receptors in immune and inflammatory diseases. Curr Top Med Chem 7: 1743-1752.
31. Bedoui S, Kawamura N, Straub RH, et al. 2003. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol 134: 1-11.
32. Wheway J, Mackay CR, Newton RA, et al. 2005. A fundamental bimodal role for neuropeptide Y1 receptor in the immune system. J Exp Med 202: 1527-1538.
33. Macia L, Yulyaningsih E, Pangon L, et al. 2012. Neuropeptide Y1 receptor in immune cells regulates inflammation and insulin resistance associated with diet-induced obesity. Diabetes 61: 3228-3238.
34. Straub RH, Schaller T, Miller LE, et al. 2000. Neuropeptide Y cotransmission with norepinephrine in the sympathetic nerve-macrophage interplay. J Neurochem 75: 2464-2471.
35. Dimitrijevic M, Stanojevic S, Mitic K, et al. 2008. The anti-inflammatory effect of neuropeptide Y (NPY) in rats is dependent on dipeptidyl peptidase 4 (DP4) activity and age. Peptides 29: 2179-2187.
36. Nunes AF, Liz MA, Franquinho F, et al. 2010. Neuropeptide Y expression and function during osteoblast differentiation-insights from transthyretin knockout mice. FEBS J 277: 263-275.
37. Inada M, Yasui T, Nomura S, et al. 1999. Maturational disturbance of chondrocytes in Cbfa1-deficient mice. Dev Dyn 214: 279-290.
38. Nakashima K, Zhou X, Kunkel G, et al. 2002. The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.